Session » T cell Biology and Targets in Autoimmune Disease Poster II

Date: Tuesday, November 10, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 3028

CD1d Regulates iNKT Cell Autoreactivity

9:00AM-11:00AM: Abstract Number: 3022

Characterizing a Novel Gene, Mosaic, and Its Role in Mediating a Multisystem Autoimmunity

9:00AM-11:00AM: Abstract Number: 3031

Dalazatide (ShK-186), a Kv1.3 Channel Inhibitor That Targets Effector Memory T Cells: Ex Vivo Studies in Pediatric Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 3023

Decreased Intracellular Calcium Flux in Follicular Helper T Cells after T Cell Receptor Stimulation

9:00AM-11:00AM: Abstract Number: 3025

FcγRIIIa-Psyk Signaling up-Regulates TLR3 and TLR5 in Human Naïve CD4+ T-Cells

9:00AM-11:00AM: Abstract Number: 3024

FcÎ³riiia Mediated Signal Cause Epigenetic Changes in Human Naive CD4+ T-Cells

9:00AM-11:00AM: Abstract Number: 3027

Hyperactivated State of Mucosal Associated Invariant T Cells Due to Activation Potency of Monocytes in Systemic Lupus Erythematous

9:00AM-11:00AM: Abstract Number: 3020

IL-21 Abrogates CD4+CD25+FOXP3+ Treg Differentiation in Part By Suppressing Treg GATA-3 Expression in SLE

9:00AM-11:00AM: Abstract Number: 3030

Increased Localization of Spleen Tyrosine Kinase (Syk) in Lipid Rafts of in Vitro TCR/CD3-CD28 Activated Lupus T Cells

9:00AM-11:00AM: Abstract Number: 3029

Increased Plasticity of Non-Classic Th1 Cells Towards the Th17 Phenotype

9:00AM-11:00AM: Abstract Number: 3021

The Adaptor Protein Crkii Regulates Rap1 Activation in the Immunological Synapse

9:00AM-11:00AM: Abstract Number: 3019

The CD4+CD52low T Cell Contributes to Disease Activity and Autoantybody Production in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 3026

The Effects of Lrg on the Differentiation of Naïve T Cells

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].